Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2.

Autor: Gonzalez Martinez OG; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Ayala Rodríguez SC; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Pappaterra-Rodriguez M; School of Medicine, Ponce Health Sciences University, Ponce, USA.; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Requejo-Figueroa G; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Oliver AL; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA.

Publikováno v: Cureus [Cureus] 2023 Jun 16; Vol. 15 (6), pp. e40528. Date of Electronic Publication: 2023 Jun 16 (Print Publication: 2023).